Considerations in Contamination Control

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2020
Volume 2020 eBook
Issue 2
Pages: 38–42

A contamination control strategy can prevent contamination in sterile product manufacturing. The right system, equipment, and personnel training are also essential to mitigate risk.

Pharmaceutical Technology spoke with Richard Denk, senior consultant aseptic processing and containment, SKAN AG, about the risks of contamination in biopharmaceutical manufacturing and how this risk can be mitigated.

Read this article in Pharmaceutical Technology Biologics and Sterile Drug Manufacturing May 2020 eBook.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2020
May 2020
Pages: 38–42

Citation

When referring to this article, please cite it as S. Haigney, “Considerations in Contamination Control," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

 

Articles in this issue
PTebook0520_PreFilled-Syringes_Main-Image.gif
On Point: Biologics Drive Growth in Pre-Filled Syringes
Screen Shot_225.jpg
Instrumenting Single-Use Processes
Ebook_Contamination Control_225.jpg
Considerations in Contamination Control
Best systems and equipment for contamination control
Ebook_Development_225.jpg
Building Data Quality In Generates Quality Data Out
PTeBook0520_ContaminationCellTherapy_main225.jpg
Detecting Contamination in Cell Therapies
PTeBook0520_SeparationViralVector_main225.jpg
Optimizing Viral Vector Manufacturing for Gene Therapy
PTEebook0520_thermo.jpg
Minimizing Contamination During Biopharma R&D
PTEebook0520_agalloco-1.jpg
Complications in Process Simulation Execution
Recent Videos
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

Patrick Lavery
April 30th 2025
Article

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CARBOGEN AMCIS Shanghai Site Gets Drug Manufacturing License from China’s NMPA

Patrick Lavery
April 24th 2025
Article
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Bavarian Nordic Chikungunya Vaccine Recommended by CDC's ACIP

Patrick Lavery
April 18th 2025
Article

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak.

compounding pharmacist at work 2 | Image Credit: ©Nadia -stock.adobe.com

Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
April 18th 2025
Article

Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.